The involvement of EP4 in intestinal inflammation is also supported by studies that found targeted deletion of EP4 resulted in increased susceptibility to colitis in a murine model system [33] and a specific EP4 agonist reduced the severity of colitis [34]. The gene discussed is PTGER4; the disease is colitis.